Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

While Abbott has underperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the ...

Abbott Laboratories (ABT) raised its quarterly dividend to $0.63 with a 60.4% free cash flow payout ratio. Abbott’s FreeStyle Libre faces a Class I recall after 860 serious injuries and 7 deaths.

Abbott Laboratories (NYSE:ABT) plans to separate its Nutrition segment into an independent publicly traded company, targeting completion after regulatory and internal approvals. The Nutrition division ...

Dexcom, known for its G-series of diabetes wearables, topped September-quarter expectations late Thursday, leading to a ...

Abbott Laboratories is now fairly valued after a 26% decline from its 2021 highs, but I maintain a Hold rating. ABT's Q1/26 saw 7.8% revenue growth, with medical devices leading, but operating income ...

Ken Griffin recently boosted stakes in AbbVie (ABBV +1.41%) and Abbott Laboratories (ABT +1.56%), according to his latest 13F. Griffin is the billionaire founder and CEO of the hedge fund company ...

Abbott Laboratories remains a Buy, driven by robust device and diagnostics growth and the strategic spin-off of its Nutrition business. Learn more about ABT stock here.

Add Yahoo as a preferred source to see more of our stories on Google. Abbott Laboratories, facing hundreds of lawsuits over safety of formula for premature babies, notches a win in federal court A ...

Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago area babies developed a dangerous intestinal disease after consuming the company's formula for premature ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. An investor considers future earnings by interacting with ...